The potential of pomegranate and its components for prevention and treatment of breast cancer

Agro Food Industry Hi-Tech

Volumn 24, Issue 5, 2013, Pages 58-61

  Wang, Lei ^a   Martins Green, Manuela ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anthocyanins; Chemopreventive; Ellagic; Luteolin; Polyphenolic; Punicic

Indexed keywords

CHEMOPREVENTIVE; ELLAGIC; LUTEOLIN; POLYPHENOLIC; PUNICIC;

ANTHOCYANINS; BIOLOGICAL ORGANS; DISEASES; FLAVONOIDS; FRUITS; UROLOGY;

PLANTS (BOTANY);

EID: 84889062076     PISSN: 17226996     EISSN: 20354606     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. World Health Organization Facts and Figures. http://www.who.int/ (last checked on Aug 1st 2013)
2. American Cancer Society. http://www.cancer.org/ (last checked on Aug 1st 2013)
3. Jordan VC. British Journal of Pharmacology,147(Suppl 1), S269-S276 (2006).
4. Miller WR, Bartlett J, et al., Oncologist, 13(8), 829-837 (2008).
5. Yarden Y. European Journal of Cancer, 37(Suppl 4), S3-S8 (2001).
6. Brennan PJ, Kumogai T, et al., Oncogene, 19(53), 6093-6101 (2000).
7. Yarden Y, Sliwkowski MX. Nat Rev Mol Cell Biol, 2(2),127-137 (2001).
8. Slamon DJ, Clark GM, et al., Science, 235(4875), 177-182 (1987).
9. Hudis CA. New England Journal of Medicine, 357(1), 39-51 (2007).
10. Seidman AD, Fornier MN, et al., Journal of Clinical Oncology, 19(10), 2587-2595 (2001).
11. Scheuer W, Friess T, et al., Cancer Research, 69(24), 9330-9336 (2009).
12. Adams CW, Allison DE, et al., Cancer Immunol Immunother, 55(6), 717-727 (2006).
13. Olayioye MA, Neve RM, et al., EMBO, 19(13), 3159-3167 (2000).
14. Burris HA, III Oncologist, 9(Suppl 3),10-15 (2004).
15. Cazzaniga M, Bonanni B. Journal of Biomedicine & Biotechnology. ID 985620 (2012).
16. Nagaraju GP, Aliya S, et al., Integrative Biology, 4(9), 996-1007 (2012).
17. Sa G, Das T. Cell Div, 3(14) (2008).
18. Jutooru I, Chadalapaka G, et al., J Biol Chem, 285(33), 25332- 25344 (2010).
19. Kuo PL, Hsu YL, et al., Mol Cancer Ther, 5(12), 3209-3221 (2006).
20. Ahmad A, Banerjee S, et al. J Cell Biochem, 105(6), 1461-1471 (2008).
21. Joe AK, Liu H, et al., Clin Cancer Res, 8(3), 893-903 (2002).
22. Tinhofer I, Bernhard D, et al., FASEB J, 15(9), 1613-1615 (2001).
23. Khan N, Afaq F, et al., Antioxidiants & Redox Signaling, 10(3), 475-510 (2008).
24. Hernandez F, Melgarejo P, et al., European Food Research and Technology, 210(1), 39-42 (1999).
25. Lansky EP, Newman RA. Journal of Ethnopharmacology, 109(2), 177-206 (2007).
26. Van Elswijk DA, Schobel UP, et al., Phytochemistry, 65(2), 233- 241 (2004).
27. Gomez-Caravaca AM, Verardo V, et al., J Agric Food Chem, 61(22), 5328-5337 (2013).
28. Ackland ML, Van de Waarsenburg S, et al., In Vivo, 19(1), 69-76 (2005).
29. Qu W, Breksa AP, et al., Food Chemistry, 132(3), 1585-1591 (2012).
30. Grossmann ME, Mizuno NK, et al., Int J Oncol, 36(2), 421-426 (2010).
31. Gasmi J, Sanderson JT. J Agric Food Chem, 58(23), 12149- 12156 (2010).
32. Kim ND, Mehta R, et al., Breast Cancer Research and Treatment, 71(3), 203-217 (2002).
33. Labrie F, Luu-The V, et al., Steroids, 62(1), 148-158 (1997).
34. Mehta R, Lansky EP. Eur J Cancer Prev, 13(4), 345-348 (2004).
35. Mehta RG. European Journal of Cancer, 36(10), 1275-1282 (2000).
36. Nakshatri H, Goulet RJ Jr. Curr Probl Cancer, 26(5), 282-309 (2002).
37. Biswas DK, Shi Q, et al., Proc Natl Acad Sci U S A, 101(27), 10137-10142 (2004).
38. Hayden MS, Ghosh S. Genes Dev, 18(18), 2195-2224 (2004).
39. Karin M. Nature, 441(7092), 431-436 (2006).
40. Streicher KL, Willmarth NE, et al., Mol Cancer Res, 5(8), 847-861 (2007).
41. Khan GN, Gorin MA, et al., Integr Cancer Ther, 8(3), 242-253 (2009).
42. Banerjee N, Talcott S, et al., Breast Cancer Research and Treatment, 136(1), 21-34 (2012).
43. Wang L, Wei D, et al., Clin Cancer Res, 9(17), 6371-6380 (2003).
44. Hirano F, Tanaka H, et al., Mol Cell Biol, 18(3), 1266-1274 (1998).
45. Mertens-Talcott SU, Chintharlapalli S, et al., Cancer Res, 67(22), 11001-11011 (2007).
46. Mertens-Talcott SU, Noratto GD, et al., Mol Carcinog, 52(8), 591-602 (2012).
47. Kerr WG. Ann N Y Acad Sci,1217, 1-17 (2011).
48. Vivanco I, Sawyers CL. Nature Reviews Cancer, 2(7), 489-501 (2002).
49. Wang L, Ho J, et al., Translational Oncology, 5(5), 344-355 (2012).
50. Rocha A, Wang L, et al., Breast Cancer Research and Treatment, 136(3), 647-658 (2012).
51. Mueller A, Homey B, et al., Nature, 410(6824), 50-56 (2001).
52. Liang Z, Yoon Y, et al., Cancer Research, 65(3):967-71 (2005).
53. Wang LM, Xie KP, et al., Asian Pac J Cancer Prev, 13(4), 1431-7 (2012).
54. Wang N, Wang ZY, et al., Breast Cancer Res Treat, 134(3), 943- 955 (2012).
55. Pantuck AJ, Leppert JT, et al., Clin Cancer Res, 12(13), 4018- 4026 (2006).
56. Paller CJ, Ye X, et al., Prostate Cancer Prostatic Dis, 16(1), 50- 55 (2013).
57. Wang L, Alcon A, et al., Integr Biol, 3(7), 742-754 (2011).